Monkeypox is a rare and potentially serious disease caused by the Monkeypox virus. It is similar in symptoms to smallpox and is primarily found in nonhuman primates and rodents, but it can also be transmitted to humans. The incubation period is 5 to 21 days, and symptoms can include fever, skin rash, chills, muscle pain, fatigue, and swollen lymph nodes. The skin rash starts on the face, hands, or legs and spreads to other parts of the body, starting as flat and then developing into blister-filled lesions that eventually scab over. In the past year, monkeypox outbreaks have been reported in non-endemic countries like the US, UK, and Europe, leading to its declaration as a Public Health Emergency of International Concern. In response, health authorities are calling for increased research into vaccines and treatments to combat the spread of the disease.
Use of Human Biospecimens in Research
Human biospecimens play a critical role in current medical research, particularly in disease diagnosis, treatment, and vaccine development. Biospecimens such as blood, tissue, and urine samples are collected from patients and used to study disease mechanisms, identify biomarkers, and test new treatments. They also play a crucial role in developing new diagnostic tools and vaccines by providing a source of material to test and validate these products. With the increasing demand for high-quality human biospecimens in research, biobanks and biospecimen providers are becoming an essential part of the medical research landscape. Through the proper collection, storage, and distribution of these samples, biobanks and biospecimen providers are enabling the discovery of new treatments and therapies to improve human health.
Central BioHub welcomes Suppliers for Monkeypox Samples.
Human biospecimens have played a crucial role in advancing COVID-19 research, highlighting the significance of well-annotated human samples in medical research. The demand for high-quality human biosamples for clinical investigations is currently high. Central BioHub, a global biospecimen provider, invites you to join their global clinical supplier network to gather Monkeypox patients samples for research. The company recognizes the value of human samples and their potential to drive the next breakthrough in medical innovation. They aim to prevent monkeypox cases from becoming another pandemic by working with local biospecimen suppliers and biobanks worldwide to provide valuable monkeypox test samples or patient samples for research and development. Central BioHub invites suppliers to share their inventory of monkeypox biospecimens or monkeypox virus samples. Visit https://centralbiohub.de/blogs/let-us-stop-monkeypox-becoming-another-pandemic to learn about the benefits of collaborating with Central BioHub for monkeypox patient sample research.
